Safety of MOON101 for the Treatment of Peanut Allergy
Public ClinicalTrials.gov record NCT07580898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT07580898
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 40 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 4 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 6, 2026
- Primary completion
- Dec 30, 2027
- Completion
- Dec 30, 2027
- Last update posted
- May 13, 2026
2026 – 2027
United States locations
- U.S. sites
- 5
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Research Institute | Little Rock | Arkansas | 72202 | — |
| Children's Healthcare of Atlanta | Atlanta | Georgia | 30329 | — |
| Dr. Vince Clinical Research | Overland Park | Kansas | 66212 | — |
| University of Michigan | Ann Arbor | Michigan | 48106 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Peanut Allergy trials
Other public records listing Peanut Allergy. Sorted by last update posted; newest first. Not a recommendation.
- NCT07768371: A 52-week Study of Remibrutinib in IgE-mediated Food Allergy Recruiting
- NCT07015996: Efficacy of Tezepelumab in Peanut Oral Immunotherapy Not yet recruiting
- NCT07117669: Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants Recruiting
- NCT04222491: Food Oral Immunotherapy for Peanut Allergy Active, not recruiting
- NCT05476497: Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects Active, not recruiting
- NCT05621317: A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07580898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07580898 live on ClinicalTrials.gov.